SD Arthritis Medical Clinic is categorized under Doctors in Chula Vista, CA .
SD Arthritis Medical Clinic was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Belen Acosta, Office Manager at the company’s single location by writing to 1310 3rd Avenue # B3, Chula Vista, California CA 91911 or by phoning (619) 827-0296. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | SD Arthritis Medical Clinic |
| Contact Person: | Belen Acosta, Office Manager |
| Address: | 1310 3rd Avenue # B3, Chula Vista, California 91911 |
| Phone Number: | (619) 827-0296 |
| Website Address: | sandiegoarthritis.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
SD Arthritis Medical Clinic was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Belen Acosta, Office Manager for inquiries that concern SD Arthritis Medical Clinic by calling the company number (619) 827-0296, as your correspondence is most welcome. Additionally, the physical location of the single location of SD Arthritis Medical Clinic can be found at the coordinates 32.60605,-117.06617 as well as the street address 1310 3rd Avenue # B3 in Chula Vista, California 91911.
For its online presence, you may visit SD Arthritis Medical Clinic’s website at sandiegoarthritis.com and engage with its social media outlets through on Twitter and on Facebook.